Acuitive Technologies has filed a notice of an exempt offering of securities to raise $6,180,000.00 in New Equity and Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Acuitive Technologies is raising $6,180,000.00 in new funding. Sources indicate that as part of senior management Chief Operating Officer, David Washburn played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Acuitive Technologies
Founded in 2014, Acuitive Technologies is a medical device manufacturer committed to advancing the art and science of orthopedic surgery by developing material science technologies and unique device designs that more effectively address the clinical problems facing current state of the art orthopedic devices. The foundation of our materials portfolio is CITREGEN, a paradigm-changing synthetic biomaterial purposefully designed on a molecular level to replicate the intrinsic cellular support network.
To learn more about Acuitive Technologies, visit http://www.acuitivetech.com/
Contact:
David Washburn, Chief Operating Officer
201-661-2673
https://www.linkedin.com/in/dave-washburn-34752710/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.